ArticleBone reports2022

A case report to assess the safety and efficacy of Burosumab, an investigational antibody to FGF23, in a single pediatric patient with Epidermal Nevus Syndrome and associated hypophosphatemic rickets.

Carson Huynh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.